Yonsei University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yonsei University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11527
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yonsei University (Yonsei) is an educational service provider that offers training and research services. The university offers graduation programs in various areas such as applied statistics, architectural engineering, Asian studies, astronomy, atmospheric sciences, biochemistry, bio convergence, biological science and technology, biology, biomedical engineering, chemical engineering, chemistry, chemistry and biochemistry, child and family studies and Chinese language and literature, among others. Its research centers include biochip research center, biometrics engineering research center and cancer metasis research center, among others. The university operates in Seodaemun and Seoul. Yonsei is located in Seoul, South Korea.

Yonsei University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yonsei University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yonsei University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yonsei University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Yonsei University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Celltrion Enters into Co- Development Agreement with Yonsei University 10
Infectious Disease Research Institute and Yonsei University Medical Center Form Joint Venture 11
Licensing Agreements 12
Amtixbio Receives Antifungal Therapy Technology from Yonsei University and Korea Institute of Science and Technology 12
Obetat Biopharma Enters into Licensing Agreement with Younsei University 13
Yonsei University – Key Competitors 14
Yonsei University – Key Employees 15
Yonsei University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Yonsei University, Pharmaceuticals & Healthcare, Key Facts 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yonsei University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yonsei University, Deals By Therapy Area, 2012 to YTD 2018 8
Yonsei University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Celltrion Enters into Co- Development Agreement with Yonsei University 10
Infectious Disease Research Institute and Yonsei University Medical Center Form Joint Venture 11
Amtixbio Receives Antifungal Therapy Technology from Yonsei University and Korea Institute of Science and Technology 12
Obetat Biopharma Enters into Licensing Agreement with Younsei University 13
Yonsei University, Key Competitors 14
Yonsei University, Key Employees 15
Yonsei University, Other Locations 16
Yonsei University, Subsidiaries 16

List of Figures
Yonsei University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yonsei University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yonsei University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Yonsei University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yonsei University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Yonsei University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hostess Brands, Inc. (TWNK):企業の財務・戦略的SWOT分析
    Hostess Brands, Inc. (TWNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Royal Bank of Canada:企業のM&A・事業提携・投資動向
    Royal Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Purdue Pharma L.P.:企業のM&A・事業提携・投資動向
    Purdue Pharma L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Purdue Pharma L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Pharmaxis Ltd (PXS)-医療機器分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • Juvenile Diabetes Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type 1 diabetes. The organization conducts clinical trials for curing, preventing and treating for type 1 diabetes and its complications; and researching new drugs for patients to manage …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Hansen Technologies Ltd (HSN):企業の財務・戦略的SWOT分析
    Summary Hansen Technologies Ltd (Hansen Technologies) is a technology company that offers customer care, billing, and meter data management software solutions. The company provides outsourcing services such as facilities management, support center, consulting, host management, business continuity, i …
  • Bryce Corporation:企業の戦略・SWOT・財務分析
    Bryce Corporation - Strategy, SWOT and Corporate Finance Report Summary Bryce Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Crown Castle International Corp (CCI):企業の財務・戦略的SWOT分析
    Crown Castle International Corp (CCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Sykes Enterprises, Incorporated:企業の戦略・SWOT・財務情報
    Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a provider of instruments, reagents, and services for molecular profiling applications. The company's products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provid …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Heartland Consumers Power District:企業の戦略的SWOT分析
    Heartland Consumers Power District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Southwest Airlines Co:戦略・SWOT・企業財務分析
    Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report Summary Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Callaway Golf Co (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Co (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kopran Ltd (KOPRAN):企業の財務・戦略的SWOT分析
    Summary Kopran Ltd (Kopran) is a pharmaceutical company that manufactures finished dosage forms and active pharmaceutical ingredients. The company’s finished dosage form includes tablets, dry powders for oral suspension, capsules, injections and syrups. It offers products in the therapeutic areas of …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Valeura Energy Inc (VLE):石油・ガス:M&Aディール及び事業提携情報
    Summary Valeura Energy Inc (Valeura) is an upstream oil and gas company that explores for, develops and produces oil and natural gas. It operates mainly in the Thrace Basin in the northwest of Turkey pursuing conventional shallow natural gas, unconventional tight gas and a basin-centered gas accumul …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆